Condition
Tumor Metastasis
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Active Not Recruiting1
Terminated1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT03383094Phase 2Active Not Recruiting
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
NCT06175221Phase 2Terminated
Autologous TLPO Vaccine Basket
NCT05670574Not ApplicableUnknown
Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors
Showing all 3 trials